Medicine/Drugs
-
Afrezza is Failing to Lift Off
There have been poor launch sales of the new inhalable insulin system. Can it rebound?
Read More » -
FDA Requires New Warning Label on Insulin Pens
Regulators are requiring all multi-dose pens be labeled “For single patient use only”.
Read More » -
FDA Approves New Basal Insulin Toujeo
The FDA has approved Sanofi’s once-daily basal insulin, but will it compete with Sanofi’s own Lantus?
Read More » -
Smart Insulin Automatically Modifies Blood Sugar Levels
The insulin automatically stabilized high blood-sugar in mice with diabetes.
Read More » -
Good Insulin Vibrations?
Microcapsules inserted beneath the skin of mice slowly released insulin after being exposed to micro-shockwaves.
Read More » -
How Sanofi Plans to Sell Us Inhalable Insulin
We get a glimpse into the marketing strategy for Afrezza.
Read More » -
A Basal Insulin Primer
Learn why people with Type 1 diabetes need this long-acting insulin, and treatment options.
Read More » -
Treatment Options for Insulin-Sensitive Children
A diabetes educator discusses diluted insulin, which can help stave off blood sugar swings.
Read More » -
Understanding Insulin Sticker-Shock
Why are some forms of insulin so expensive, and what happens if you can't afford the price?
Read More » -
Denied Insulin in Prison
A man with Type 1 diabetes was denied insulin in a holding cell for almost a day.
Read More » -
Can I Inject Insulin into Muscle?
The latest Q&A from the mailbag of Integrated Diabetes Services.
Read More » -
An Insulin Price War?
The makers of Lantus oust their CEO partly over insulin sales. Will this lead to lower prices for basal insulin?
Read More » -
Does Insulin Make Us Fat?
We explore this issue and the science behind obesity with noted science writer Gary Taubes.
Read More » -
Why Does Pen Usage Lag in the U.S.?
The insulin pen is big in Japan, so why not here? It has a lot to do with cost.
Read More » -
Why Lantus is Dominant Right Now
Tired of paying high prices for Sanofi’s basal insulin? An alternative to Lantus has been blocked from the marketplace.
Read More » -
Dr. Banting: Called a Failure, Discovers Insulin
How a late-night idea saved the lives of thousands with diabetes and still inspires diabetes researchers today.
Read More » -
Afrezza Has Lift-Off with FDA Approval
But will the FDA’s pulmonary concerns and Exubera’s track record keep this inhalable insulin from getting serious air in the marketplace.
Read More » -
Insulin Allergies Are For Real
Modern formulas of insulin have helped curb allergy reactions, but not eliminated them. Here’s what you need to know.
Read More » -
Uncertain Access to Insulin
Elizabeth Rowley says we must speak up for those with diabetes around the world who can’t find or afford insulin and test strips.
Read More » -
Weight and T1 Can be a Heavy Subject
We sometimes forget that insulin is a hormone that can promote weight gain in people with Type 1 diabetes.
Read More »
